Dissecting the metabolic signaling pathways by which microbial molecules drive the differentiation of regulatory B cells.

NF-kB Regulatory B cells colitis microbial metabolites microbiota

Journal

Mucosal immunology
ISSN: 1935-3456
Titre abrégé: Mucosal Immunol
Pays: United States
ID NLM: 101299742

Informations de publication

Date de publication:
10 Sep 2024
Historique:
received: 05 03 2024
revised: 06 09 2024
accepted: 09 09 2024
medline: 13 9 2024
pubmed: 13 9 2024
entrez: 12 9 2024
Statut: aheadofprint

Résumé

The host-microbiome axis has been implicated in promoting anti-inflammatory immune responses. Yet, the underlying molecular mechanisms of commensal-mediated IL-10 production by regulatory B cells (Bregs) are not fully elucidated. Here, we demonstrate that bacterial CpG motifs trigger the signaling downstream of TLR9 promoting IκB

Identifiants

pubmed: 39265892
pii: S1933-0219(24)00096-5
doi: 10.1016/j.mucimm.2024.09.003
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Maik Luu (M)

Institute for Medical Microbiology and Hygiene, Philipps-University Marburg, Marburg, Germany; Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany.

Felix F Krause (FF)

Institute for Medical Microbiology and Hygiene, Philipps-University Marburg, Marburg, Germany.

Heide Monning (H)

Institute for Medical Microbiology and Hygiene, Philipps-University Marburg, Marburg, Germany.

Anne Wempe (A)

Institute for Medical Microbiology and Hygiene, Philipps-University Marburg, Marburg, Germany.

Hanna Leister (H)

Institute for Medical Microbiology and Hygiene, Philipps-University Marburg, Marburg, Germany.

Lisa Mainieri (L)

Institute for Medical Microbiology and Hygiene, Philipps-University Marburg, Marburg, Germany.

Sarah Staudt (S)

Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany.

Kai Ziegler-Martin (K)

Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany.

Kira Mangold (K)

Institute for Medical Microbiology and Hygiene, Philipps-University Marburg, Marburg, Germany; Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany.

Nora Kappelhoff (N)

Institute for Medical Microbiology and Hygiene, Philipps-University Marburg, Marburg, Germany.

Yoav D Shaul (YD)

Department of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

Stephan Göttig (S)

Institute for Medical Microbiology and Infection Control, University Hospital, Goethe University, Frankfurt am Main, Germany.

Carlos Plaza-Sirvent (C)

Department of Molecular Immunology, Ruhr-University Bochum, Bochum, Germany.

Leon N Schulte (LN)

Institute for Lung Research, Philipps-University Marburg, Marburg, Germany.

Isabelle Bekeredjian-Ding (I)

Institute for Medical Microbiology and Hygiene, Philipps-University Marburg, Marburg, Germany.

Ingo Schmitz (I)

Department of Molecular Immunology, Ruhr-University Bochum, Bochum, Germany.

Ulrich Steinhoff (U)

Institute for Medical Microbiology and Hygiene, Philipps-University Marburg, Marburg, Germany.

Alexander Visekruna (A)

Institute for Medical Microbiology and Hygiene, Philipps-University Marburg, Marburg, Germany. Electronic address: alexander.visekruna@staff.uni-marburg.de.

Classifications MeSH